v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Operating expenses:        
Research and development $ 20,209 $ 9,855 $ 40,183 $ 15,493
General and administrative 6,915 7,455 13,554 12,590
Total operating expenses 27,124 17,310 53,737 28,083
Loss from operations 27,124 17,310 53,737 28,083
Other expense (income), net:        
Interest income (2,488) (2,984) (5,218) (4,009)
Interest expense 734 728 1,486 1,291
Loss on extinguishment of debt       366
Other expense (income), net 205 (91) 168 (27)
Total other income, net (1,549) (2,347) (3,564) (2,379)
Net loss before income taxes 25,575 14,963 50,173 25,704
Provision for (recovery of) income taxes 240 21 258 (9)
Net loss 25,815 14,984 50,431 25,695
Other comprehensive loss (income):        
Unrealized gain on available-for-sale investments (306)   (450)  
Total comprehensive loss (income) $ 25,509 $ 14,984 $ 49,981 $ 25,695
Net loss per share of common shares, basic $ 0.51 $ 0.38 $ 0.99 $ 0.82
Net loss per share of common shares, diluted $ 0.51 $ 0.38 $ 0.99 $ 0.82
Weighted-average common shares outstanding, basic 51,019,363 39,443,768 50,997,987 31,186,238
Weighted-average common shares outstanding, diluted 51,019,363 39,443,768 50,997,987 31,186,238